H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on CollPlant to $11 from $26 and keeps a Buy rating on the shares following the Q4 results. At the end of Q4, CollPlant had approximately $30M in cash and cash equivalents, which is sufficient to fund operations into the "foreseeable future," the analyst tells investors in a research note.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CLGN: